(EXA) Exail Technologies S.A. - Overview
Stock: Navigation, Sonar, Drones, Photonics, Fiber
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 66.4% |
| Relative Tail Risk | -10.7% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.61 |
| Alpha | 453.38 |
| Character TTM | |
|---|---|
| Beta | -0.011 |
| Beta Downside | 0.269 |
| Drawdowns 3y | |
|---|---|
| Max DD | 42.72% |
| CAGR/Max DD | 1.80 |
Description: EXA Exail Technologies S.A. January 14, 2026
Exail Technologies (PA:EXA) is a French-based engineering firm that designs, manufactures, and sells high-technology solutions across robotics, maritime navigation, aerospace, and photonics. Its product portfolio spans navigation and positioning systems, sonar equipment, maritime drones, specialty optical fibers, optical modulators, and quantum measurement instruments, as well as integrated communication and simulation systems for autonomous decision-making.
Key market drivers that could influence EXA’s growth include: (1) the EU’s defense modernization agenda, which is projected to raise aerospace & defense spending by ~3-4% CAGR through 2028; (2) the global maritime autonomous surface vessel market, expected to expand at a 12% annual rate, creating demand for EXA’s drone and sonar offerings; and (3) the photonics sector’s rapid expansion, with specialty fiber revenues growing ~9% YoY, supporting higher margins for quantum-grade components. According to the latest (unverified) filings, EXA reported roughly €150 million in revenue for FY2023, with R&D expenses representing about 12% of sales-a level consistent with peers focused on advanced hardware development.
For a deeper quantitative assessment, consult the ValueRay platform’s detailed valuation model to explore EXA’s upside potential.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: -4.18m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 2.15 > 1.0 |
| NWC/Revenue: 8.30% < 20% (prev 14.04%; Δ -5.74% < -1%) |
| CFO/TA 0.13 > 3% & CFO 114.0m > Net Income -4.18m |
| Net Debt (310.0m) to EBITDA (83.7m): 3.70 < 3 |
| Current Ratio: 1.18 > 1.5 & < 3 |
| Outstanding Shares: last quarter (17.0m) vs 12m ago -0.26% < -2% |
| Gross Margin: 39.92% > 18% (prev 0.39%; Δ 3954 % > 0.5%) |
| Asset Turnover: 82.25% > 50% (prev 62.67%; Δ 19.58% > 0%) |
| Interest Coverage Ratio: 0.65 > 6 (EBITDA TTM 83.7m / Interest Expense TTM 52.8m) |
Altman Z'' 1.35
| A: 0.07 (Total Current Assets 380.9m - Total Current Liabilities 322.5m) / Total Assets 898.3m |
| B: 0.10 (Retained Earnings 90.3m / Total Assets 898.3m) |
| C: 0.04 (EBIT TTM 34.5m / Avg Total Assets 855.8m) |
| D: 0.31 (Book Value of Equity 215.3m / Total Liabilities 700.4m) |
| Altman-Z'' Score: 1.35 = BB |
Beneish M -3.17
| DSRI: 0.77 (Receivables 193.8m/181.3m, Revenue 703.8m/509.6m) |
| GMI: 0.97 (GM 39.92% / 38.76%) |
| AQI: 0.88 (AQ_t 0.47 / AQ_t-1 0.54) |
| SGI: 1.38 (Revenue 703.8m / 509.6m) |
| TATA: -0.13 (NI -4.18m - CFO 114.0m) / TA 898.3m) |
| Beneish M-Score: -3.17 (Cap -4..+1) = AA |
What is the price of EXA shares?
Over the past week, the price has changed by -0.72%, over one month by +15.34%, over three months by +47.38% and over the past year by +457.36%.
Is EXA a buy, sell or hold?
What are the forecasts/targets for the EXA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 131.9 | 20.1% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 171 | 55.7% |
EXA Fundamental Data Overview February 03, 2026
P/E Trailing = 1580.0
P/E Forward = 67.1141
P/S = 4.1411
P/B = 16.6021
Revenue TTM = 703.8m EUR
EBIT TTM = 34.5m EUR
EBITDA TTM = 83.7m EUR
Long Term Debt = 265.4m EUR (from longTermDebt, last quarter)
Short Term Debt = 44.5m EUR (from shortTermDebt, last quarter)
Debt = 341.3m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 310.0m EUR (from netDebt column, last quarter)
Enterprise Value = 2.19b EUR (1.88b + Debt 341.3m - CCE 31.3m)
Interest Coverage Ratio = 0.65 (Ebit TTM 34.5m / Interest Expense TTM 52.8m)
EV/FCF = 22.79x (Enterprise Value 2.19b / FCF TTM 96.0m)
FCF Yield = 4.39% (FCF TTM 96.0m / Enterprise Value 2.19b)
FCF Margin = 13.64% (FCF TTM 96.0m / Revenue TTM 703.8m)
Net Margin = -0.59% (Net Income TTM -4.18m / Revenue TTM 703.8m)
Gross Margin = 39.92% ((Revenue TTM 703.8m - Cost of Revenue TTM 422.8m) / Revenue TTM)
Gross Margin QoQ = 51.44% (prev 9.64%)
Tobins Q-Ratio = 2.43 (Enterprise Value 2.19b / Total Assets 898.3m)
Interest Expense / Debt = 3.48% (Interest Expense 11.9m / Debt 341.3m)
Taxrate = 27.86% (582.0k / 2.09m)
NOPAT = 24.9m (EBIT 34.5m * (1 - 27.86%))
Current Ratio = 1.18 (Total Current Assets 380.9m / Total Current Liabilities 322.5m)
Debt / Equity = 3.02 (Debt 341.3m / totalStockholderEquity, last quarter 112.9m)
Debt / EBITDA = 3.70 (Net Debt 310.0m / EBITDA 83.7m)
Debt / FCF = 3.23 (Net Debt 310.0m / FCF TTM 96.0m)
Total Stockholder Equity = 122.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.49% (Net Income -4.18m / Total Assets 898.3m)
RoE = -3.43% (Net Income TTM -4.18m / Total Stockholder Equity 122.0m)
RoCE = 8.91% (EBIT 34.5m / Capital Employed (Equity 122.0m + L.T.Debt 265.4m))
RoIC = 5.63% (NOPAT 24.9m / Invested Capital 442.7m)
WACC = 5.36% (E(1.88b)/V(2.22b) * Re(5.88%) + D(341.3m)/V(2.22b) * Rd(3.48%) * (1-Tc(0.28)))
Discount Rate = 5.88% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.13%
[DCF Debug] Terminal Value 87.33% ; FCFF base≈85.4m ; Y1≈94.9m ; Y5≈124.4m
Fair Price DCF = 197.8 (EV 3.67b - Net Debt 310.0m = Equity 3.36b / Shares 17.0m; r=5.90% [WACC]; 5y FCF grow 12.97% → 2.90% )
EPS Correlation: -28.61 | EPS CAGR: 0.0% | SUE: 0.0 | # QB: 0
Revenue Correlation: 73.52 | Revenue CAGR: 51.58% | SUE: 1.60 | # QB: 1
EPS next Year (2026-12-31): EPS=1.84 | Chg30d=-0.159 | Revisions Net=+0 | Growth EPS=+120.1% | Growth Revenue=+19.8%